The Cost Of A Cure: Patent Rights And Drug Prices
U.S. patients pay much higher prices for drugs than patients overseas, effectively subsidizing patients worldwide.
U.S. patients pay much higher prices for drugs than patients overseas, effectively subsidizing patients worldwide.
A federal jury has awarded $2.54 billion in royalties to Merck, ruling against Gilead in a monumental patent infringement case involving two blockbuster hepatitis C drugs.
This Pro Bono Week, get inspired to give back with PLI’s Pursuing Justice: The Pro Bono Files, a one-of-a-kind podcast hosted by Alicia Aiken.